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ABSTRACT: Biofilms are prevalent in chronic wounds and once formed are very hard to remove which is associated with 
poor outcomes and high mortality rates. Biofilms are comprised of surface-attached bacteria embedded in an extracellular 
polymeric substance (EPS) matrix, which confers increased antibiotic resistance and host immune evasion. Therefore, dis-
ruption of this matrix is essential to tackle the biofilm embedded bacteria. Here we propose a novel nanotechnology to do 
this, based on protease-functionalized nanogel carriers of antibiotics. Such active antibiotic nanocarriers, surface coated with 
the protease Alcalase 2.4 L FG, "digest" their way through the biofilm EPS matrix, reach the buried bacteria and deliver a high 
dose of antibiotic directly on their cell walls which overwhelms their defenses. We demonstrated their effectiveness against 
six wound biofilm forming bacteria, Staphylococcus aureus, Pseudomonas aeruginosa, Staphylococcus epidermidis, Klebsiella 
pneumoniae, Escherichia coli and Enterococcus faecalis. We confirmed a six-fold decrease in the biofilm mass, and a substantial 
reduction in bacterial cell density using fluorescence, atomic force and scanning electron microscopy. Additionally, we 
showed that co-treatments of ciprofloxacin and Alcalase-coated Carbopol nanogels led to a 3-log reduction in viable biofilm 
forming cells when compared to ciprofloxacin treatments alone. Encapsulating an equivalent concentration of ciprofloxacin 
into the Alcalse-coated nanogel particles boosted their antibacterial effect much further, reducing the bacterial cell viability 
to below detectable amounts after 6 hours of treatment. The Alcalase-coated nanogel particles were non-cytotoxic to human 
adult keratinocyte cells (HaCaT), inducing a very low apoptotic response in these cells. Overall, we demonstrated that the 
Alcalase-coated nanogels loaded with a cationic antibiotic elicit very strong biofilm clearing effects against wound associated 
biofilm forming pathogenic bacteria. This nanotechnology approach has the potential to become a very powerful treatment 
of chronically infected wounds with biofilm forming bacteria.
INTRODUCTION 
Biofilms are microbial communities surrounded by a struc-
ture referred to as extracellular polymeric substance (EPS), 
composed of biopolymers such as exopolysaccharides, nu-
cleic acids, lipids, and proteins.1 The EPS matrix is highly hy-
drated, with occasional hydrophobic regions, such as areas 
containing cellulose.2 Combined, these substances form a 
structured matrix, allowing bacteria to effectively adhere to 
a range of surfaces.3  The formation of biofilms begins when 
surface-attached bacterial cells secrete EPS which allows 
complex communal tertiary microcolony structures to 
form.4 Biofilms are commonly surface-attached with one 
layer of cells in direct contact with the substratum, how-
ever, they can be found in flocs in which biofilms are formed 
around cells without contact with a substratum.5 The EPS 
matrix provides effective protection of the bacteria within 
the biofilm to a wide array of environmental factors, such as 
antimicrobial agents and a host immune response mole-
cules.6,7 Biofilms confer benefits to the cells within, in 
quenching antimicrobial agents which would kill planktonic 
cells.8 The biofilm is able to impair the diffusion of antimi-
crobial agents through the EPS and lower local concentra-
tion, thus increasing the tolerance of the cells to the most 
chemicals.9 An example of tolerance is the neutralization of 
toxic metal ions such as copper which is complexed to the 
polysaccharides of the EPS.10,11 Biofilm infections in humans 
with species which show high resistance to treatment may 
result in chronic infections.16 Opportunistic pathogens such 
as, Staphylococcus, Pseudomonas and Klebsiella genus’, can 
form biofilms on acute and chronic dermal wounds, impair-
ing wound healing, and potentially leading to sepsis.17 This 
effect can lead to increased patient mortality and morbidity 
in regard to biofilm infection.18,19 Nanoparticles (NPs) have 
been investigated for their anti-biofilm properties.  Ag-Au 
nanocomposite particles, CuONPs, Mg(OH)2 NPs, silica NPs 
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and Au NPs have shown high efficacy in this re-
gard.21,22,12,64,13 Borovicka et al.37,45,46 developed photother-
mal colloid antibodies based on bioimprints that can selec-
tively kill microbial cells by cell shape recognition. Au NPs 
in conjunction with heat produced with laser irradiation 
can effectively disrupt biofilms.23 Taking advantage of the 
antimicrobial effect of Ag has led to the novel use of bioglass 
which incorporates surface reacted Ag and has been shown 
to have effective anti-biofilm use.24 Enzymatic biofilm deg-
radation has also been investigated, e.g. the use of hydro-
lases, amylases, and proteases.25 The principle of disrupting 
the biofilm network using enzymatic lysis, rather than di-
rectly attacking the cells themselves has the advantage of 
not relying on the biocidal action of tradition antimicrobials, 
and as such do not place a direct evolutionary pressure on 
the bacteria to develop resistance.26 All components of the 
EPS matrix have been investigated for the removal of bio-
films, these include DNases, glycosidases, and proteases.27 
An examples of a glycosidases is dispersin B produced 
by Aggregatibacter actinomycetemcomitans, has been 
demonstrated as being effective against S. epidermidis and 
S. aureus biofilms.28,29  Glycoside hydrolase alginate lyase 
and DNase NucB has also proved effective against P. aeru-
ginosa and E. coli biofilms respectively.30,31 Proteases (EC 
3.4) are present in all life forms, providing a wide variety of 
metabolic and physiological functions, including signal 
transduction, apoptosis, cell division, blood pressure regu-
lation, and many more.32  Protease have previously been in-
vestigated for their anti-biofilm potential, both as small 
molecules (e.g. ficin) and bacterial-derived Bacillus prote-
ases (AprBp and GseBp).33,34 Ironically, bacteria have be-
come a useful source of anti-biofilm proteases.35,36 Prote-
ases have two unique properties which make them an ex-
cellent enzyme choice for degrading biofilms. Their ability 
to hydrolyze EPS matrix proteins and adhesins (allowing a 
biofilm to attach to a solid surface and bacteria-bacteria ad-
hesion) give them a distinct advantage over other anti-bio-
film enzymes.1 Additionally, they may disrupt intercellular 
communication by lysis of type I signal peptidase, as shown 
in S. aureus.39 Proteases have also been shown to have po-
tential in improving wound healing by degrading the bio-
film EPS which may be interfering with the normal wound 
healing process.40,41 Serine Esp based protease obtained 
from S. epidermidis and elastase LasB from P. aeruginosa 
have been shown to reduce biofilm formation in S. aureus, 
providing further evidence of their efficacy and usefulness 
in biofilm treatment options.42  
Figure 1.  (A) Schematic for the loading of the Carbopol Aqua SF1 nanogel with antibiotic (ABX+) followed by surface 
coating with protease (Alcalase 2.4 L FG).  (B) Diagram of the mechanism of action of the Carbopol Aqua SF1-Alcalase 
2.4 L FG nanogel particles on biofilms adhered to a substrate. Alcalase 2.4 L FG acts as a hydrolases cleaving peptide 
chains. It also acts as an esterase, enabling it to catalyze stereo-selective hydrolysis of some esters including carbox-




In addition to the evidence that exogenous protease de-
grade biofilms, it has been shown that in the natural self-
induced disassembly of biofilms, bacteria induce expression 
of extracellular proteases to cleave matrix proteins.44 Some 
of these extracellular proteases include sigB and sarA, 
which have all been shown to reduce biofilm capacity in S. 
aureus.47 Novozymes® (Denmark) produce a wide array of 
enzymes produced by Bacillus spp. (Gram-positive, rod-
shaped, spore-forming bacteria) which have applications in 
industry and biopharmaceutical ingredients, many with 
useful activity properties as mentioned above.38  It has been 
demonstrated that immobilization of proteases can in-
crease their stability, reusability, and increase their toler-
ance of environmental stresses.48 Covalent bonding, ionic 
interactions, entrapment/encapsulation in a polymer or in-
organic matrices and hydrophobic adsorption have previ-
ously been demonstrated as methods to immobilize en-
zymes.49 Although immobilization can improve the enzyme 
activity, stability and storage life, there is also the possibility 
of enzyme rigidification, particularly in strong covalent 
techniques, which reduce the effective activity of the en-
zyme.50  Nanoparticle carriers such as chitosan beads and 
soybean fibers have been shown to be useful biocompatible 
carriers for proteins and also increase the activity of Al-
calase.51,52 
In this study, we investigated the use of Carbopol Aqua SF1 
nanogels as a substrate to immobilize a Serine endo-pepti-
dase proteases, namely Alcalase 2.4 L FG (Figure 1 illus-
trates the process). Polyacrilic acid co-polymer nanogels 
have cross-linked polymer chains which due to the abun-
dance of COOH groups confer an anionic charge upon their 
surface and interior.53  These nanogel particles have shown 
good biocompatibility and have been found to be effective 
in encapsulating cationic antimicrobials such as chlorhexi-
dine digluconate, and tetracycline and lincomycin hydro-
chloride.54,55  Nanocarrier-based antibiotic delivery pro-
vides an opportunity to increase the effectiveness of thera-
peutic agents by specifically targeting bacteria due to their 
anionic cell wall54,55  (e.g. utilizing cationic coatings of the 
nanogel such as PDAC and bPEI), localizing the drug whilst 
reducing the unintended damaging effect on neighboring 
tissue. Since Alcalase 2.4 L FG has a very high isoelectric 
point, it is positively charged at neutral pH. We took ad-
vantage of the negative surface charge of Carbopol Aqua SF1 
nanogel particles to electrostatically immobilize Alcalase 
2.4 L FG on their surface. We investigated the stability of Al-
calase 2.4 L FG coated Carbopol Aqua SF1 nanoparticles, 
and evaluated their potential anti-biofilm use on skin asso-
ciated pathogens which are known to produce biofilms. Ad-
ditionally, we investigated the potential synergistic effect of 
antibiotic co-treatments and encapsulations within the 
nanogel using ciprofloxacin hydrochloride, combined with 
further surface coating of the loaded nanogel with Alcalase 
2.4 L FG. Our study demonstrates that there is a strong syn-
ergistic clearing effect of these novel dual functionalized 




Carbopol Aqua SF1 nanogel (30 wt% aqueous suspension) 
was provided by Lubrizol, USA. Six American Type Culture 
Collection (ATCC) bacterial species were used in this study.  
Staphylococcus aureus subsp. aureus Rosenbach (ATCC® 
29213™), Pseudomonas aeruginosa (Schroeter) Migula 
(ATCC® 27853™), Staphylococcus epidermidis (Winslow 
and Winslow) Evans (ATCC® 35984™), Klebsiella pneu-
moniae subsp. pneumoniae (Schroeter) Trevisan (ATCC® 
35657™), Escherichia coli (Migula) Castellani and Chalmers 
(ATCC® 25922™), and Enterococcus faecalis (Andrewes and 
Horder) Schleifer and Kilpper-Balz (ATCC® 51299™).  
Mueller-Hilton Broth (MHB), Mueller-Hilton Agar (MHA) 
were supplied by Oxoid, UK.  Alcalase 2.4 L FG EC number; 
3.4.21.62 was kindly provided by Novozymes, Denmark. Al-
calase 2.4 L FG is a Serine endo-peptidase (mainly subtilisin 
A) which performs stereo-selective hydrolysis of amino es-
ters and selective esters. Alcalase also efficiently hydrolyses 
amino esters which include heterocyclic amino esters. Opti-
mal conditions for usage are 30–65°C and pH 7–9. Its enzy-
matic activity is 2.4 AU-A/g.  The protein concentration of 
Alcalase 2.4 L FG was 55 mg/mL, determined by a 
NanoDrop™ Lite Spectrophotometer (Thermo Scientific, 
UK).  Millipore Express PLUS Membrane Filter paper (0.22 
µm pore size, hydrophilic polyethersulfone, 47 mm diame-
ter), Ciprofloxacin hydrochloride (≥98.0%), Acridine Or-
ange base (75%) and Resazurin Sodium salt (75%) were 
purchased from Sigma-Aldrich, UK. Resazurin Sodium salt 
was used for cell metabolic in situ assays and diluted in Dul-
becco’s Phosphate Buffered Saline (DPBS) (Gibco, Fisher 
Scientific, UK) at a concentration of 0.015 wt/vol%. HaCaT 
cells were obtained from AddexBio, T0020001, USA. DMEM 
and FBS were obtained from Gibco, UK, L-Glutamine and 
Trypsin EDTA by BioWhittaker, UK. A PierceTM Protease As-
say Kit (Thermo Scientific, USA) was used to characterize 
the Alcalase 2.4 L FG activity. A MTT colorimetric survival 
and proliferation kit (Millipore Corp, USA) was used for Ha-
CaT cell viability experiments and ANNEXIN V apoptosis de-
tection Kit I (BD Pharmogen, USA) was used to measure 
apoptosis after treatments. Deionized water purified by re-
verse osmosis and ion exchange with a Milli-Q water system 
(Millipore, USA) was used in all our studies. Its surface ten-
sion was 71.9 mN m–1 at 25 °C, with measured resistivity 
higher than 18 MΩ cm–1. Consumable plasticware used in 
the study were purchased from Sarstedt (UK), Thermo Sci-
entific (UK), or CytoOne (UK) unless otherwise stated. 
Synthesis of Alcalase-coated nanogel particles. Carbopol 
Aqua SF1 (30 wt%) was diluted into 0.6 wt% by pipetting  2 
mL of the stock suspension (30 wt%) and diluting with de-
ionized water to a final volume of 100 mL. This suspension 
was sonicated for 15 min using 2 second on/off pulsing to 
allow effective dispersion.  Droplets 0.25 M HCl was added 
to the suspension to reduce the pH to 5.5.  A 0.6 wt% solu-
tion of Alcalase L FG 2.4 was created by diluting 0.6 mL of 
the stock liquid enzyme solution and diluting with deion-
ized water to a final volume of 100 mL. The 0.6 wt% Alcalase 
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solution was sonicated for 15 min to prevent aggregation. 
25 mL of the 0.6 wt% Carbopol Aqua SF1 suspension and 25 
mL of the 0.6 wt% Alcalase L FG 2.4 solution were mixed 
together for 30 min at pH 5.5 with constant stirring to allow 
the cationic enzyme to electrostatically bind to the anionic 
Carbopol NPs. After mixing the suspension was centrifuged 
at 4000 rpm for 15 min the pellet was washed trice with de-
ionized water and then dispersed into 50 mL of fresh deion-
ized water. Droplets of acetate buffer solution were used to 
maintain the dispersion at 5.5 pH. The supernatant was re-
tained for analysis to determine the surface functionaliza-
tion efficiency by UV-Vis absorption measurement. The par-
ticle size and zeta potential distribution of the Carbopol-Al-
calase NPs were measured using a Malvern Zetasizer as de-
scribed below. Prior to measurement, and use of the nano-
gels in treatments, the 0.6 wt% Carbopol-0.6 wt% Alcalase 
dispersion was sonicated for 5 min to remove aggregation 
and diluted into deionized water to the appropriate concen-
tration. 
Preparation of ciprofloxacin-loaded nanogel. The princi-
ple of encapsulating a cationic antibiotic (as a hydrochloride 
salt) is based on the swelling and deswelling cycle of the Carbo-
pol Aqua SF1 at different pH.53 Briefly, a 100 mL of 0.6 wt% 
aqueous dispersion of the nanogel was prepared, this was then 
adjusted to pH 7.5 by adding droplets of 0.25 M NaOH whilst 
been stirred. The dispersion was then warmed to 37 °C. An ali-
quot of 0.0032 wt% ciprofloxacin hydrochloride aqueous dis-
persion was prepared by weighing 3.2 mg of the antibiotic (ABX 
= ciprofloxacin) powder, diluting into 100 mL of deionized wa-
ter and then warming to 37 °C. The 100 mL ABX solution was 
then added to the pH 7.5 nanogel dispersion and shaken for 30 
min at 37 °C to allow the antibiotic cations to diffuse into and 
electrostatically bind in the cores of the swollen nanogel parti-
cles. The pH of the ABX–Carbopol solution was then reduced to 
pH 5.5 using droplets of 0.25 M HCl whilst being stirred for an-
other 30 min. The ABX–Carbopol suspension was then centri-
fuged at 4000 rpm for 15 min, and the supernatant was re-
moved and retained for encapsulation efficiency analysis. The 
pellet was washed twice with deionized water and re-dispersed 
into 100 mL of deionized water. The pH was then increased to 
7.5 by gradually adding droplets of 0.25 M NaOH and the solu-
tion was gently stirred overnight. The final ABX–Carbopol 
nanogel solution was reduced to pH 5.5 using acetate buffer so-
lution. The particle size and zeta potential distribution of the 
ATX–Carbopol dispersion were measured using a Malvern 
Zetasizer Nano ZS as described above. Coating of the ciproflox-
acin encapsulated Carbopol NPs with Alcalase 2.4 L FG was per-
formed as described above. 
Characterization of free Alcalase, Alcalase-nanogel and 
Alcalase-coated Ciprofloxacin-loaded nanogel. All hy-
drodynamic diameter and zeta potential measurements 
were performed using a Malvern Zetasizer Nano ZS. The iso-
electric point of Alcalase L FG 2.4;  10 mL of 0.02 wt% aque-
ous solution Alcalase aliquots were created at a range of pH 
5 to 12 using droplets of either 0.25 M HCl or 0.25 M NaOH. 
Afterwards, the aliquots were sonicated for 15 min. 1 mL of 
each aliquot was added to a quartz cuvette and the zeta po-
tential measured using a ZEN1002 dip cell at a refractive in-
dex of 1.45 and absorption of 0.001 as per Malvern Instru-
ments protein refractive index manual. Measurements were 
performed at 25 oC and data represented as the mean of 3 
repeats.  
Hydrodynamic diameter and zeta potential of Alcalase-
nanogel and Alcalase-nanogel loaded with Ciprofloxa-
cin.  50 mL of pH 5.5 0.6 wt% Carbopol-0.6 wt% Alcalase L 
FG 2.4 NPs and 0.6 wt% Carbopol-0.0032 wt% ciprofloxa-
cin-0.6 wt% Alcalase-nanogel dispersions were prepared as 
described above.  Aliquots of 0.6 wt% Carbopol were mixed 
with varying concentrations of Alcalase L FG 2.4 (range; 
0.000625 wt% to 0.6 wt%).  The hydrodynamic diameter 
and zeta potential were measured at 25 oC using a quartz 
cuvette at a RI of 1.336 and absorbance of 1.000 as deter-
mined by Al-Awady et al.53 Each measurement was repeated 
3 times and data presented as the mean. The UV-Visible 
spectrum of 0.05 wt% Carbopol, 0.05wt% Alcalase 2.5 L FG 
and 0.05 wt% Carbopol with 0.05 wt% Alcalase 2.4 L FG 
coating.  Samples were measured at pH 5.5 by adjustment 
with acetate buffer solution.  The absorbance was measured 
between 220 nm and 1000 nm using a FLUOstar Omega 
spectrophotometer, BMP Labtech. The Alcalase coating effi-
ciency of the Carbopol NPs was examined by UV-Vis analy-
sis of the supernatant produced during the synthesis as de-
scribed above. The absorbance of the supernatant was 
measured at 500 nm using a spectrophotometer (FLUOstar 
Omega spectrophotometer, BMP Labtech).  
Protease activity of free Alcalase vs. nanogel-immobi-
lized Alcalase. The activity of free Alcalase 2.4 L FG vs Al-
calase 2.4 L FG-Carbopol Aqua SF1 NPs was investigated by 
measuring the cleavage of succinylated casein in the pres-
ence of 0.2 wt% Alcalase, or 0.2 wt% Alcalase-0.2 wt% Car-
bopol NPs at varying pH, temperature, and over time. 10 mg 
of lyophilized succinylated casein was dissolved in 1 mL of 
acetate buffer (pH 5.5), PBS (pH 7.5), or BupH Borate buffer 
(pH 8.5). For the purpose of the temperature and time ex-
periments acetate buffer was used for all measurements, 
mimicking the buffer used in the NP preparation. 100 μL of 
this solution was added to a 96-well plate, and 100 μL of 
buffer was added to bring the total volume to 200 μL in each 
well. 100 μL of plane buffer was used as a blank. 50 μL of 
either free Alcalase 2.4 L FG vs. Alcalase 2.4 L FG-Carbopol 
Aqua SF1 NPs was added to the wells. The activity of the 
samples was measured at different pH (using buffers above) 
for 30 min at room temperature, over time (30 mins to 24 
hr) at room temperature, or at different temperatures (30 
oC, 37 oC, and 45 oC) for 30 min. 100 μL of trinitrobenzene-
sulfonic acid was dissolved in 14.9 mL of appropriate buffer 
to create a TNBSA working solution. Succinylated casein in 
the presence of proteases is cleaved at the peptide bonds 
revealing primary amine groups. TNBSA reacts with these 
groups to produce an orange-yellow product of which the 
absorbance can be measured at 450 nm informing of prote-
ase activity of the samples. The protease activity of the free 
protease vs nanogel-coated protease  were measured at 
specific time points by adding 50 μL of the TNBSA solution 
to the wells and incubating for 20 min. Then, the absorbance 
of the wells was measured at 450 nm subtracting the ab-




Figure 2.  (A) Hydrodynamic diameter and (D) isoelectric point of 0.6 wt% Alcalase 2.4 L FG measured using a Mal-
vern zetasizer Nano ZS at 25 oC.  Each value represents a triple replicate with ± S.D.  (B) The mean particle hydrody-
namic diameter and (C) mean zeta potential of Alcalase 2.4 L FG coated Carbopol nanogel particles measured at pH 
5.5 (acetate buffered saline) with various concentrations of Alcalase mixed with an equal wt% of Carbopol Aqua SF1 
NPs.  (E) The zeta potential of 0.6 wt% Alcalase 2.4 L FG coated “empty” 0.6 wt% Carbopol nanogel particles at pH 5.5 
(adjusted with acetate buffered saline) measured at various time intervals after preparation. The refractive index of 
either particles was taken as 1.336. Each value represents average triplicate measurements with error bars repre-
senting the ± S.D. The lines are guides to the eye. (F)  The UV-Visible spectrum of 0.05 wt% Carbopol (red line), 0.05 
wt% Alcalase 2.5 L FG (Blue line) and 0.05 wt% Carbopol with 0.05 wt% Alcalase 2.4 L FG coating (green line). Sam-
ples were measured at pH 5.5 adjusted by acetate buffer. The absorbance was measured between 220 and 1000 nm 
using a FLUOstar Omega spectrophotometer. 
 
This data was used to assess the relative protease activity of 
the free Alcalase 2.4 L FG vs Alcalase 2.4 L FG-Carbopol 
Aqua SF1 nanogels at different experimental conditions.  
Bacterial culture and biofilm producing assessment. 
Frozen ATCC species were prepared onto MHA plates ac-
cording to manufacturer’s instructions. Overnight (O/N) 
cultures were prepared by incubating a single colony 
scraped from the MHA stock plates into 10 mL of MHB for 
16 hr at 37 oC with 140 rpm shaking (Stuart Orbital Incuba-
tor S1500). For biofilm assays, O/N cultures were adjusted 
to 0.5 McFarland standard by diluting the O/N culture into 
0.85 w/v% sterile saline until an optical density of 0.08-0.12 
at 625 nm (1-2×108 CFU/mL) was obtained using a spectro-
photometer (FLUOstar Omega spectrophotometer, BMP 
Labtech). These adjusted bacterial saline suspensions were 
then diluted 1:150 into MHB to yield starting concentra-
tions between 5×105 – 1×106 colony forming units per mL 
(CFU mL-1). All 6 ATCC species used in this study have pre-
viously been confirmed as biofilm producers, however, to 
validate this, a simple qualitative biofilm formation assess-
ment was performed. 2 mL of MHB was placed into glass 
test tubes and inoculated with a single colony of bacteria 
from culture plates. The test tubes where incubated for 24 
hr at 37 °C. Afterward, the culture media was decanted and 
the test tubes washed with PBS (pH 7.4), and left to dry for 
30 min. 0.1 wt% Crystal Violet was used  to  stain cells ad-
hered to the glass tubes for 5 min, before being washed 
away with deionized water. The  test  tubes  where  then left  
to  dry  in an  inverted  position for  2  hr. Biofilm formation 
was considered positive when a visible film lined the wall 
and the bottom of the tube. Ring formation at the liquid in-
terface was not indicative of biofilm formation. The for-
mation of biofilm by staining of the adhered cells was scored 
as either 0-absent, 1-weak, 2-moderate or 3-strong, as per-
formed by Christensen et al.56 
Zeta potential of bacteria treated with free Alcalase and 
Alcalase-coated nanogel. Bacterial species were cultured 
as described in as described above. The bacterial suspen-
sion was then centrifuged for 10 min at 5000 rpm and the 
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supernatant discarded. The pellet was washed twice with 
deionized water and finally resuspended into 10 mL of 0.2 
wt% Alcalase or 0.2 wt% Alcalase-0.2 wt% Carbopol Aqua 
SF1 in deionized water.  The samples were incubated at 
room temperature with gentle mixing for 10 min or 1 hrs.  
Afterwards, a 1 mL aliquot of this suspension was added to 
a quartz cuvette and the mean zeta potential distribution 
was measured using the Dipstick probe and a Malvern 
Zetasizer Nano ZS (Malvern Instruments, UK). The refrac-
tive index was 1.384, the absorption 1.000, and the temper-
ature was 25 oC for all measurements. 
Biofilm staining with Crystal Violet and Congo Red. A 
standard 96-well microtiter biofilm formation plate assay 
was performed using crystal violet and Congo Red dyes 
(modified from O’Toole, 2011).57 Crystal Violet staining:  1 
mL of 5×105 – 1×106 CFU/mL of O/N bacterial culture was 
pipetted into 48-well TC-treated plates and incubated at 37 
oC for 24 hrs in static conditions. After incubation, the plates 
were washed twice by submerging in deionized water to re-
move any remaining media and suspended cells. The plate 
was then shaken dry and left to air dry for 15 mins at room 
temperature. 1 mL of MHB supplemented with Carbopol-Al-
calase synthesized NPs treatment was added to the wells 
and incubated for 24 hrs at 37 oC in static conditions. The 
plates were then washed vigorously by submersion in de-
ionized water to remove excess treated media and sus-
pended cells. The  plate  was  then  shaken  to  remove  any 
liquid  droplets  and  left  to  dry  for  15  mins  at  room 
temperature.  1 mL of 0.1 wt% Crystal Violet solution was 
added to each well and incubated at room temperature for 
15 mins. The plates were then washed thoroughly by sub-
mersion in deionized water and blotted with paper towels 
to remove excess dye and water. The plate was left to dry 
for 2 hrs at room temperature.  1 mL of 30 wt% acetic acid 
was added to each well for 15 min to solubilize to the Crystal 
Violet. 125 μL of this solution was transferred to a fresh 96-
well plate and the absorbance measured at 570 nm with 30 
wt% acetic acid used as a blank measurement. Congo Red 
staining: As described above, 48-well plate biofilms were 
formed and treated with 1 mL of MHB supplemented Car-
bopol-Alcalase nanogel suspension.  After the treatment, 
the enzyme-infused MHB media was removed and the 48-
well plate washed thoroughly by submerging in water. The 
plate was then shaken to remove liquid droplets and left to 
dry for 15 mins at room temperature.  125 μL of 0.005 wt% 
Congo Red was added to each well and left to stain the am-
yloid protein complexes for 15 mins. The 96-well plate was 
then washed thoroughly again by submersion in deionized 
water and blotted with paper towels to remove excess 
Congo red dye and water.  The plate was left to dry for 2 hrs 
at room temperature. 125 μL of 30% ethanol was added to 
each well for 15 mins to solubilize to the Congo Red dye. 125 
μL of this solution was transferred to a fresh 96-well plate 
and the absorbance measured at 550 nm with 30% ethanol 
used as a blank sample. 
Membrane Colony Biofilm NP and Ciprofloxacin treat-
ment. To test the effects of Alcalase-Carbopol nanogel and 
ciprofloxacin co-treatments on biofilms a filter membrane 
method was employed. 2 cm2 Millipore Express PLUS Mem-
brane Filter paper sections were placed on to MHA. An over-
night culture was adjusted to 1×105 CFU/mL in saline and 
20 μL of this culture added as a droplet to the center of the 
filter paper. The sample was then incubated for 24 hours at 
37 oC to allow a colony biofilm to form.  After 24 hrs the 
membranes were placed onto fresh agar plates (3mm deep) 
into a 6-well plate and 1 mL of treatment added to each well. 
The plate was gently shaken in the incubator during treat-
ment. 1 mL of deionized water was considered the growth 
control. 0.6 wt% Carbopol, 0.6 wt% Alcalase 2.4 L FG in de-
ionized water, and 0.6 wt% Carbopol-0.6 wt% Alcalase 2.4 
L FG NPs were used as treatments to the measure their ef-
fect on the cell viability. Additionally, ciprofloxacin hydro-
chloride was added separately and as a co-treatment with 
the Carbopol-Alcalase NPs at a range of 0 to 32 μg/mL 
(0.0032 wt%).  Equivalent concentrations of encapsulated 
ciprofloxacin tested as a comparison. After 24 hrs of treat-
ment, the membrane filter paper was peeled from the agar 
wells and placed in to sample tube with 1 mL of fresh MHB 
and 2 cm of sterile glass beads. Each sample was vortexed 
for 30 secs at high speed to disintegrate the biofilm and in-
oculated the MHB with cells. The drop plate enumeration 
method was used to measure cell viability in CFU/mL. To 
measure the viability of cells within the biofilms, 10-fold di-
lutions were made in fresh MHB, 10 μL droplets were placed 
on to MHA plates and grown for 24 hrs at 37 oC. CFUs were 
counted from the last two droplets which contained a count-
able amount of colonies (3 to 30 colonies per 10 μL drop) 
and averaged. 
Resazurin Sodium Salt in situ bacterial metabolic activ-
ity assay. After the 24-hr membrane colony biofilm NP 
treatment, as described above, each membrane biofilm was 
carefully removed from the agar plate using sterile twee-
zers at the corner of the membrane. The membrane biofilm 
was allowed to air dry in sterile conditions for 15 min and 
then placed onto a dry sterile Petri dish. 20 μL of 0.015 wt% 
Resazurin Sodium Salt was added and incubated for 30 min 
at 37 oC to visualize the metabolically active cells within the 
biofilm (modified from Wilkinson et al.58). Images were cap-
tured using an 8MP digital camera and the percentage of cell 
metabolic activity calculated using ImageJ v1.52a. 
Biofilm formation assay on a glass surface. An overnight 
culture of each species was adjusted to 0.5 McFarland 
standard.   10 μL of the adjusted culture was placed into a 
Petri plate containing a glass slide and 10 mL of MHB and 
incubated for 48 hrs at 37 oC allowing the bacterial species 
to form a glass slide adhered biofilm. After 24 hrs the glass 
slide was washed with deionized water to remove any re-
maining planktonic cells, and the media was replaced with 
10 mL of fresh MHB supplemented with 0.6 wt% Carbopol, 
0.6 wt% Alcalase L FG, and 0.6 wt% Carbopol-0.6 wt% Al-
calase 2.4 L FG. Un-supplemented media was considered the 
control. The glass biofilms were incubated for a further 24 
hrs at 37 oC.  Post treatment, the glass slides were washed 
with deionized water. 100 μL 0.2 wt% Acridine Orange (AO) 
was added to the Petri dish and incubated at room temper-
ature for 5 mins in darkness with gentle shaking to reduce 
photobleaching. After incubation, the slides were washed 
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three times with deionized water and allowed to air dry for 
15 mins.  The slides were examined using an Olympus BX51 
fluorescent microscope with DP70 digital camera. 
Atomic force microscopy (AFM). AFM images of the air-
dried biofilms were obtained using a Dimension Icon scan-
ning probe microscope (Bruker, USA) using tapping mode.  
The biofilms were prepared and treated as described above 
in the glass surface biofilm formation assay. Post treatment, 
the glass slide biofilms were washed gently with deionized 
water, and the biofilm fixed in 1 wt% aqueous glutaralde-
hyde for 2 hrs by submersion. After fixation, the slide was 
washed three times with deionized water and left to air dry 
inside an enclosed container.  TESPA-V2 probes (Bruker, 
USA) with a nominal length of 127 μm and a tip radius of 7 
nm were used, the images obtained at 512 lines/scan at a 
0.25 Hz scan rate.  Images were acquired in height (topog-
raphy) and the analyzed using Nanoscope Analysis v.1.7. 
(Bruker, USA).  
TEM images of Alcalase-nanogel and SEM images of the 
treated biofilms. SEM images of membrane colony biofilms 
were obtained. Post treatment the membrane was gently re-
moved from the agar using sterile tweezers and placed onto 
a 7 mm diameter circular glass slide and adhered using Car-
bon discs. The excess membrane was trimmed from the 
edges of the glass slide using sterile scissors. The biofilm 
was gently washed with deionized water to remove excess 
media and treatment.  The biofilms were then fixed in a 1 
wt% glutaraldehyde PBS buffer solution for 1 hr at room 
temperature.  After fixation, the biofilms were washed 
3 times gently with deionized water to remove excess 
glutaraldehyde. The samples were then dehydrated in 
50%/75%/90% and absolute ethanol solutions for 30 
min per each ethanol concentration. The absolute etha-
nol was dried using liquid CO2 at its critical point using 
an E3000 Critical Point Dryer (Quorum Technologies, 
UK) and then coated in 10 nm carbon layer. Samples 
were imaged with variable pressure 100-micron aperture 
at 40 Pa. EHT 20 kV, probe current 100 pA. Images were 
captured with Zeiss smartSEM software (Zeiss Evo-60 SEM, 
Germany).  TEM images of bare Carbopol Aqua NPs, free Al-
calase 2.4 L FG protease, and Alcalase 2.4 L FG coated Car-
bopol Aqua SF1 nanogels were obtained by placing a drop-
let of the suspended sample onto carbon-coated copper 
grids (EM Solutions, UK) and allowed to adhere for 2 min. 
The grid was quickly rinsed with deionized water and neg-
atively stained with 1 wt% aqueous uranyl acetate. This was 
again quickly rinsed with deionized water, allowed to dry in air 
and then imaged with a Gatan Ultrascan 4000 digital camera at-
tached to the Jeol 2010 TEM 2010 electron microscope (Jeol, Ja-
pan) running at 120kV.  
EDX data was collected via an Oxford Instruments Nano-
analysis X-Max 65-T detector and INCA software. 
Cytotoxicity and apoptotic stasis of HaCaT spontane-
ously transformed keratinocytes from histological nor-
mal skin after treatment with nanogel, Alcalase and Al-
calase-nanogels. HaCaT cells were cultured in T75 flask us-
ing DMEM supplemented with 10% FBS and 1% L-gluta-
mine under humidified conditions at 37 °C, 5% CO2. When a 
confluency of 80% was achieved, determined by visualiza-
tion with an optical microscope, passaging was performed 
to ensure that the cells remained in the exponential phase 
for experimentation. Passaging was performed by removing 
spent media, washing in DPBS and incubating with 1 × tryp-
sin EDTA at 37 °C 5% CO2 for 5 min until the cells were de-
tached in suspension. The trypsin EDTA was then neutral-
ized with a 1 : 1 volumetric ratio of fresh DMEM and gently 
centrifuged at 400 rpm for 4 min, the supernatant was aspi-
rated, and the pellet was re-suspended in DMEM (supple-
mented as above) at a 1 : 6 ratio and transferred into a fresh 
T75 flask. Experimental cells were diluted in fresh DMEM, 
supplemented with 2% FBS and 1% L-glutamine and 
seeded at 5 × 104 in 100 μL media, were placed into 96-well 
plate wells and incubated for 24 hours at 37 °C 5% CO2. The 
medium was then removed and the cells and replaced with 
100 μL of treatment infused DPBS. The treatments with only 
DPBS were used as a control, 0.6 wt% Carbopol, 0.6 wt% 
free Alcalase, and 0.6 wt% Alcalase – 0.6 wt% Carbopol 
nanogel were used as treatments. DPBS was used so DMEM 
peptones did not interfere with the true activity of the Al-
calase. Treatments were performed for 1, 6, and 24 hrs time 
points. A colorimetric (MTT) cell survival and proliferation 
assay kit was used to measure cell viability. Treatment cul-
ture was aspirated away and the cells washed for 2 min with 
fresh DPBS. 100 μL of fresh DMEM was added after which 
100 μL of MTT reagent (50% 3-(4,5-dimethylthiazol-2-
yl)2,5-diphenyl tetrasodium bromide and 50% PBS) was 
added. This was incubated in the same conditions for 2 hrs 
until intracellular purple formazan crystals were visible un-
der a light microscope. After 2 hrs, 100 μL of color develop-
ment reagent in isopropanol with 0.04 M HCl was added for 
1 hr, allowing the cells to lyse and the formazan crystal to 
be solubilized to a homogenous blue solution. The absorb-
ance of the blue solution was read at 570 nm on a plate 
reader and subtracted from a blank of media only. These 
data were calculated into cell count data using the Beer–
Lambert extinction coefficient law using absorbance values 
from a fixed number of cells in media. The HaCaT cell viabil-
ity assay was repeated in three independent experiments. 
The induction apoptosis was investigated using a FITC An-
nexin V staining kit according to manufactures instructions. 
Apoptosis was measured after 24 hrs exposure to 0.6 wt% 
Alcalase-0.6 wt% Carbopol nanogel. Briefly, post treatment 
the cells were washed twice with DPBS and detached from 
the 96-well surface using a mini-cell scraper and re-sus-
pended in 1X binding buffer at a concentration of 1×106 
cells mL-1. 5 μL of FITC Annexin V and 5 μL of Propidium Io-
dide (PI) solution to 100 μL of the cell suspension. The cells 
were then incubated at room temperature for 15 mins in 
darkness with gentle shaking. After incubating, 400 μL of 1X 
binding buffer was added to the cell samples which were 
then placed quantified by flow cytometry (BD FACSCalibur, 
USA). The Annexin V fluorescence was measured using a 
FITC-FL1 detector, and PI measured using a FL2 phyco-
erythrin signal detector. The experiment was ended after 
10,000 cells were counted, the data was analyzed by a dot 
plot scatter and percentages of live, dead, and apoptotic 





Figure 3.  (A-B)  TEM images of 0.6 wt% Alcalase 2.4 L FG samples counterstained in 1 wt% uranyl acetate for 1 min 
during preparation. (C) TEM images of 0.6 wt% “empty” Carbopol Aqua SF1 nanogel particles; (D) TEM images of the 
nanoparticles after coating with 0.6 wt% Alcalase 2.5 L FG. Partial aggregation has occurred during the sample evap-
oration. All samples were counter-stained in 1 wt% uranyl acetate for 1 min during preparation. TEM images were 
obtained using a JEM 2010 (JOEL, Japan) at 120kV, and a Gatan Ultrascan 4000 digital camera. (E) EDX spectra of 0.6 
wt% Carbopol Aqua SF1 nanoparticles and (F) 0.6 wt% Carbopol Aqua SF1 nanogel particles coated with 0.6 wt% 
Alcalase 2.4 L FG.  A Nanoanalysis X-Max 65-T detector and INCA software were used to produce the elemental anal-
ysis spectra. 
 
Statistical analysis. Data were expressed as average values 
± standard deviations of the mean. P-values of less than 0.05 
were considered significant.  All Student’s t-tests were per-
formed in GraphPad v7.0.4. 
RESULTS AND DISCUSSION 
Coating and immobilization of Alcalase 2.4 L FG on to 
Carbopol Aqua SF1 nanogel particles. A colloidal suspen-
sion of Carbopol Aqua SF1 was chosen as an appropriate 
nanocarrier for investigating the immobilization Alcalase 
2.4 L FG protease on their surface. The lightly cross-linked 
carboxylic groups confer a net anionic surface charge corre-
sponding to a zeta-potential of approximately -30 mV at a 
pH of 5.5. This allows it to be used as a substrate to immo-
bilize the cationic protein on its surface. We chose to limit 
this suspension to 0.6 wt% to prevent the aggregation of the 
nanogel particles. Alcalase 2.4 L FG has a diameter of ~ 8 nm 
as shown from the dynamic light scattering size distribution 
and TEM micrographs (see Figure 2A and 3A-B, respec-
tively).  Data in Figure 2D shows that Alcalase 2.4 L FG has 
an isoelectric point of ~ 9 and a pH 5.5 has a zeta potential 
of ~ +18 mV. This allows a successful ionic interaction be-
tween the anionic Carbopol NPs and the cationic Alcalase 
2.4 L FG. Figure 2C shows the bare 0.6 wt% Carbopol NPs 
have a hydrodynamic diameter of approximately 110 nm, 
however, when coated with 0.6 wt% Alcalase 2.4 L FG (Fig-
ure 2D) the particles mean diameter is increased to approx-
imately 120 nm. Figure 2B confirms this through measure-
ment of the hydrodynamic diameter of the Alcalase-coated 
collapsed nanogel particles. Figure S2 (ESI) shows a com-
parison between the bare Carbopol and Alcalase coated Car-
bopol nanogels. It can be seen that by increasing the concen-
tration of the Alcalase, the coated Carbopol NPs average 
particle size also increases. This can be seen in the TEM im-
ages on Figure 3D, where the corona of the collapsed nano-
gel particles can be seen coated with a “halo” of the Alcalase 
protein molecules. The successful coating of the Alcalase on 
the Carbopol NPs was also confirmed using UV-Vis spectro-
photometry. Figure 2F shows that Alcalase has a distinct ab-
sorption peak at ~ 245 nm, however, the bare Carbopol 
shows no such peak. When the Alcalase has coated the Car-
bopol particles, a small peak also at ~ 245 nm can be seen, 
indicating the Carbopol and Alcalase have ionically inter-
acted and formed a composite Alcalase-coated Carbopol 
particles. Figure S3 (ESI) shows each of the formulations 
visually.  The stability of the Alcalase-coated Carbopol nano-
gel particles was also investigated.  
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Figure 2E shows that over 24 hrs, the zeta potential was sta-
ble in the range between 16-20 mV.  This indicates the Al-
calase remains electrostatically deposited in the nanogel 
particles over 24 hrs, indicating that it is a stable carrier for 
immobilization of the enzyme during treatment. Addition-
ally, we investigated the EDX spectra of the bare and coated 
Alcalase-nanogels using samples prepared for TEM. (see 
Figure 3E-F). The EDX spectra are similar, however, a sulfur 
peak can be seen in the coated sample spectra, which is not 
present in the uncoated nanogel. The bare nanogel formula-
tion contains only C, O, and N, so the presence of S, an ele-
ment commonly found in protein indicates that the protein 
has electrostatically bound to the Carbopol nanogel parti-
cles. Fourier Transform Infra-Red spectroscopy (FTIR) was 
used to investigate the composition of the Carbopol/Al-
calase/Ciprofloxacin NPs at a range of 600 cm-1 to 4000 cm-
1 (Figure S4, ESI). Carbopol Aqua SF1 shows a strong peak 
at 3350 cm-1. This indicates stretching vibrations of O–H 
and intermolecular hydrogen bonding. Strong peaks are 
also seen at 3005 cm-1 and 1698 cm-1 correlating to strong 
stretching of aliphatic C-H and strong vibration of carbonyl 
(C=O) bonds. Peaks at 1000 cm-1 and 1195 cm-1 indicate 
coupling between in-plane O-H bending and C-O stretching 
of neighboring carboxyl groups. Alcalase 2.4 L FG shows 
weak peaks at 2950 cm-1 and 3001 cm-1, which are charac-
teristic of amino acid with aromatic side chains e.g. tyrosine, 
tryptophan and phenylalanine. The peak at 1753 cm-1 indi-
cates strong C=O stretching, attributed to C=O bond adja-
cent to secondary amide (peptide) bond. The peak at 1156 
cm-1 shows strong C-O-H group stretching, present in the 
amino acids serine and tyrosine.  Ciprofloxacin hydrochlo-
ride shows a peak at 1451 cm-1 attributed to the strong vi-
bration of C-H bonds. The peak 1255 cm-1 is associated with 
the aromatic C-F group present on ciprofloxacin. Peak 801 
cm-1 is interpreted as tetra-substituted benzene ring deriv-
atives, present on the ciprofloxacin chemical structure. The 
tightly packed range of peaks between 600 cm-1 to 1450 cm-
1 indicates an array of substituted groups associated with 
the ciprofloxacin chemical structure. Ciprofloxacin encap-
sulated Carbopol, coated with Alcalase contains peaks asso-
ciated with the individual components. The peak at 3358 
cm-1 shows stretching vibrations of O–H and intermolecular 
hydrogen bonding, this is analogous to Carbopol alone. The 
peak at 1721 cm-1 provides evidence strong C=O stretching, 
attributed to C=O bond adjacent to secondary amide (pep-
tide) bond, present in this formulation due to the coating ef-
fect on the Carbopol surface.  High density peaks at 600 - 
1000 cm-1 again are similar to ciprofloxacin alone, which in-
dicates that a variety of substituted groups associated with 
the ciprofloxacin being present within the Carbopol. The el-
emental analysis of Carbopol Aqua SF1, Alcalase 2.4 L FG 
and Ciprofloxacin alone, and Ciprofloxacin-loaded Carbopol 
nanogel coated with Alcalase 2.4 L FG was performed using 
a CHN Analyzer (Carlo Erba 1108) (Table S6, ESI). The for-
mulated nanogel particles where centrifuged for 15 min at 
4000 rpm. The supernatant was discarded and the pellet 
washed 3 times with deionized water.  The precipitate was 
further dried overnight at room temperature under vac-
uum. The data shows the % value of C, H, N and S for the 
above materials. Carbopol alone contained only C and H, 
which is consistent with polyacrylic acid polymers.  Oxygen 
is present in all samples but not analyzed. Alcalase con-
tained C, H, and N, present in all amino acids, additionally it 
contained 0.48% S, which is present in the amino acids me-
thionine and cysteine. This is confirmed by the EDX results 
in Figure 3F.  Ciprofloxacin contains C, H and N.  
The formulation of 0.6 wt% Carbopol Aqua SF-1-0.0032 
wt% Ciprofloxacin-0.6 wt% Alcalase 2.4 L FG nanogel con-
tained all elements analyzed, confirming that the Alcalase 
had been successful retained on the Carbopol during prep-
aration.  EDX spectra of the 0.6 wt% Carbopol-0.0032 wt% 
Ciprofloxacin-0.6 wt% Alcalase nanogel, and the individual 
components was performed on SEM prepared samples (Fig-
ure S5, ESI). It can be seen that the formulation contains 
both sulfur and fluorine peaks, characteristic of Alcalase 
and ciprofloxacin respectively.  This provides evidence the 
formulated nanogel has successfully encapsulated ciprof-
loxacin and is coated with Alcalase. Alcalase 2.4 L FG was 
chosen as a potential protease to degrade biofilms due to its 
favorable activities (see Figure S6, ESI).  It is highly active 
and stable between pH 6-9 in wide temperature range be-
tween 30–65 oC.  Table S1 (ESI) also shows its optimal usage 
conditions are between 30–65°C and pH 7-9 (Novozymes 
data). These properties make it an ideal choice of bacterial 
biofilms which are grown at 37 oC and can grow at either 
acidic or basic conditions.59  
Protease activity of free Alcalase vs. Alcalase-nanogel. 
Enzyme catalytic potential is affected by several factors. We 
investigated the effect of pH, temperature and time on the 
free enzyme, and the surface immobilized Alcalase on the 
Carbopol nanogel particles (Figure S7, ESI). The effect of pH 
was investigated at 5.5, 7.5, and 8.5. As seen in Figure S7A, 
a higher pH increases the activity of the free Alcalase, and 
Alcalase-nanogel substantially. There is only a marginal dif-
ference between the protease performances of each sample, 
which is likely due to the gentle electrostatic attraction be-
tween the anionic Carbopol nanogel particles, and the cati-
onic protease in this pH range, having little effect on the en-
zymes tertiary structure. Covalent enzyme immobilization 
methods have been shown to cause a decrease in protease 
activity for this reason.60 A similar trend is observed when 
measuring the effect of temperature (Figure S7B) on the ac-
tivity of the free and immobilized Alcalase. Its activity 
broadly increased at physiological and higher tempera-
tures, a common feature of biologically derived enzymes, 
but there is very little difference in performance between 
the samples. This data is in agreement with the enzyme ac-
tivity data provided by Novozymes® (see Figure S6). This 
provides further evidence the Carbopol nanogel immobili-
zation technique is exerting little influence on the enzyme 
activity. Figure S7C examines the effect time has the activity 
of the free and immobilized samples. As like pH and temper-
ature there is only a small difference in activity, particularly 
up until 6 hr. At the 24 hrs time point, the immobilized Al-
calase-Carbopol nanogel show and increased activity com-




Figure 4. The ability of 0.2 wt% Alcalase 2.4 L FG and 0.2 wt% Carbopol-0.2 wt% Alcalase 2.4 l FG to disrupt biofilms. 
Bacteria were cultured in MHB broth for 24 hrs at 37 oC to form a biofilm. The excess media and suspended cells were washed 
away and the remaining mature biofilm incubated for 24 hrs in supplemented MHB. After the treatment, the residual biofilms 
were quantified using Crystal Violet staining.  Tests were performed in triplicates (N=3 with ± S.D). Statistical analysis shown 
in Table S3 (ESI). P <0.05 is considered significant. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
 
This indicated that over time the Alcalase-nanogel can out-
perform the free Alcalase at equivalent concentration. How-
ever, it is concluded from this data that the immobilization 
progress is not allowing the enzyme functionalized nanogel 
to perform better due to any intrinsic property the Carbopol 
is inferring, but rather the nanogel allow the enzyme to con-
centrate and localize at key anionic structures of the biofilm, 
such as the cell wall, or biofilm surface adherence pro-
teins.61  
Qualitative biofilm producing capability assessment of 
representative ATCC bacterial species. Before assess-
ment of the Alcalase 2.4 L FG coated Carbopol NPs on bio-
films, the ability of the six types of bacteria to produce bio-
films was investigated.  A simple glass tube Crystal Violet 
staining assay was used to assess their adherence to a 
smooth glass surface after 24 hrs of growth. Table S2 (ESI) 
shows that all six species were able to adhere to the glass 
tube. The adhered cells and biofilm was relatively scored 
based on the concentration of Crystal Violet dye retained af-
ter washing with deionized water. Figure S8 (ESI) shows the 
blue/purple coating of the glass over the area in which the 
bacterial cells were cultivated and adhered to the glass wall 
in a biofilm. S. aureus, P. aeruginosa, and S. epidermidis were 
shown to have strong adherence. K. pneumoniae and E. coli 
showed moderate adherence, and finally, E. faecalis was 
shown to have a weaker adherence. Staphylococcal, Pseudo-
monas, Escherichia, and Enterococcus species have all been 
previously shown to form biofilms. A Congo Red agar cul-
ture method, first demonstrated by Freeman et al.,62 was 
also performed (see Figure S9, ESI). This uses a highly nu-
tritional agar supplemented with sucrose, encouraging the 
production of exopolysaccharides. Biofilm producing spe-
cies produce black colonies, which can be seen on the S. au-
reus, P. aeruginosa, and S. epidermidis species. However, this 
was not expressed so well on the K. pneumoniae, E. coli, and 
E. faecalis species, although there was some darkening of 
the colonies. The sensitivity and the exact mechanism of the 
production of the black colonies is not well understood, and 
as it has been suggested by Freeman et al.62 that it may be 








Figure 5.  The ability of 0.2 wt% Alcalase 2.4 L FG and 0.2 wt% Carbopol Aqua SF1-0.2 wt% Alcalase 2.4 l FG to disrupt matrix 
protein by hydrolysis. Bacteria were cultured in MHB broth for 24 hrs at 37 oC to form a biofilm. The excess media and suspended 
cells were washed away and the remaining mature biofilm incubated for 24 hrs in supplemented MHB. After treatment, the residual 
biofilms were quantified using Congo Red staining.  Tests were performed in triplicates (N=3 with ± S.D). Statistical analysis shown 
in Table S4 (ESI). P<0.05 is considered significant. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
We therefore, have referred to the Crystal Violet tube 
method which shows that all six species are biofilm produc-
ers.  
Biofilm disruption by Alcalase-coated nanogel parti-
cles. Proteolytic enzymes have previously been used, par-
ticularly in wound healing applications, as agents to remove 
necrotic tissue and cell debris.33,63,65,66 We investigated if Al-
calase 2.4 L FG coated Carbopol nanogels were able to dis-
rupt the biofilms formed by the species described above. 
Biofilms were formed by culturing the bacterial species in 
TC-coated 48-well plates for 24 hr at 37 oC in static condi-
tions. After 24 hrs, the media was removed and the biofilms 
adhered to the well plates were washed to remove any re-
maining planktonic cells. Fresh culture media was supple-
mented with 0.2 wt% Carbopol, 0.2 wt% Alcalase, and 0.2 
wt% Alcalase coated Carbopol nanogel, un-supplemented 
media was used as a control. 0.1 wt% Crystal Violet was 
used to stain the adhered cells and biofilm matrix, before 
being solubilized in 30% acetic acid. The absorbance was 
taken to quantify the residual biofilm mass. Figure 4 shows 
that bare 0.2 wt% Carbopol nanogel showed very little bio-
film disruption capability, approximately a 5% reduction in 
biofilm mass. 0.2 wt% free Alcalase showed a marked im-
provement in biofilm mass reduction. This ranged from 
around 80% to 40% residual biofilm left, with P. aeruginosa 
and K. pneumoniae showing the least and most reduction in 
biofilm mass respectively. Interestingly, across all six spe-
cies the 0.2 wt% Alcalase coated 0.2 wt% Carbopol nanogel 
showed a much greater reduction in biofilm mass compared 
to the free Alcalase enzyme. This ranged from around 35% 
to 15% residual biofilm mass compared to the control. In S. 
aureus, P. aeruginosa, S. epidermidis, E. coli, and E. faecalis 
there was an over 50% decrease in the biofilm mass com-
pared to the free Alcalase alone. K. pneumoniae showed a 
20% decrease in the biofilm mass compared to the free Al-
calase. Figure S10 (ESI) shows visually the reduction in 
Crystal Violet staining on the biofilms after treatment. To 
test the hydrolysis of the biofilm matrix, particularly the 
protein content, the same experiment was performed using 
0.005 wt% Congo Red to stain the biofilm.  
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Figure 6.  Resazurin sodium salt in situ bacterial biofilm as-
say.  Membrane biofilms were grown for 24 hrs at 37 oC.  20 
μL of treatment was applied as a droplet to the surface of 
the biofilm and left to incubate for 24 hr.  20 μl of 0.015 
wt% Resazurin sodium salt was added and incubated for 
30 minutes. Images were captured using an DP70 8MP dig-
ital camera and the percentage of biofilm showing meta-
bolic activity calculated using ImageJ.  
 
This was solubilized in 30% ethanol and the absorbance 
taken to quantify the intensity of the staining of the biofilms 
after treatment. Congo Red has previously been used to 
stain amyloidosis, an accumulation of proteins, in histology 
sections. Increased concentrations of protein result in a 
more intense red staining. Figure 5 shows a similar correla-
tion between the reduction of the biofilm mass observed by 
Crystal Violet staining. 0.2 wt% Carbopol nanogel showed 
no reduction to very little reduction of the protein content 
(see Figure S11 (ESI) for visual images of Congo Red biofilm 
stains). Free 0.2 wt% Alcalase showed between a 40% to 
60% residual protein content within the biofilms.  However, 
0.2 wt% Alcalase coated 0.2 wt% Carbopol shows a much 
more impressive reduction in protein content within the 
biofilm, between 25% and 15 % residual protein compared 
to the control. This shows that the Alcalase coated nanogels 
are causing the degradation of the protein backbone of the 
biofilm. The immobilized Alcalase on Carbopol nanogel par-
ticles are likely resulting in an increase in enzyme stability 
and reduction in aggregation, allowing them to outperform 
their free enzyme counterparts.  
Resazurin sodium salt in situ bacterial biofilm meta-
bolic activity assay. Resazurin Sodium Salt assay was used 
to measure the metabolic activity of the bacterial cells 
within the biofilm.  Biofilms of the six species were growth 
for 24 hrs on Membrane Filter paper sections placed on to 
MHA. After 24 hrs of growth a biofilm was formed on the 
filter paper. The membrane biofilm was then transferred 
onto fresh MHA in a 6-well plate and submerged into treat-
ment infused deionized water (Un-supplemented deionized 
water was used as the control). Treatments were increased 
to 0.4 wt% and 0.6 wt% Alcalase to investigate if higher con-
centrations of free Alcalase enzyme, and Alcalase-coated 
Carbopol nanogels would affect the viability of the cells 
within the biofilm after 24 hrs 0.015 wt% Resazurin sodium 
salt was used to measure the metabolic activity of the cells 
within the biofilm by applying evenly to the surface of the 
biofilm. Resazurin sodium salt can be used as a metabolic 
activity assay by measuring the production of resorufin (flu-
orescent pink) created in the presence of cellular NADH.67 
Only metabolically activity cells are able to reduce resazurin 
to resorufin. The development of resorufin on the biofilm 
was quantified to measure the metabolic activity of the bio-
film after treatments. Figure 6 shows that 0.6 wt% Carbopol 
has no effect on the metabolic activity of the bacterial cells.  
0.4 and 0.6 wt% free Alcalase was able to reduce the meta-
bolic activity of cells within the biofilm by on average 60% 
to 40% across the six species. S. epidermidis showed by far 
the most decreased metabolic activity, 30% to 20 % viabil-
ity with 0.4 and 0.6 wt% free Alcalase treatment. P. aeru-
ginosa and E. faecalis were able to tolerate the free enzyme 
treatments much better, reducing to approximately 60 to 
50% after treatment with 0.4 and 0.6 wt% free Alcalase, re-
spectively. In agreement with the 48-well biofilms de-
scribed above, the Alcalase-coated Carbopol nanogel per-
formed much better than the equivalent concentration of 
the free Alcalase enzyme. In all six species, the 0.6 wt% Al-
calase – 0.6 wt% Carbopol nanogel were able to reduce the 
viability of the biofilms to approximately 4%. Figure S13 
(ESI) shows the intensity of the purple color of biofilm after 
treatment with 0.6 wt% Alcalase – 0.6 wt% Carbopol. This 
contrasts the control image which shows a pink color indi-
cating the biofilm contains metabolically active cells. 
S. aureus biofilm cellular viability after treatment with 
Alcalase-nanogel particles and co-treatment with free 
ciprofloxacin hydrochloride. Alcalase-coated Carbopol 
nanogel has been shown to reduce the biofilm mass, the 
protein concentration of biofilm matrix, and biofilm meta-
bolic activity. We decided to investigate the viability of the 
cells with in the biofilms after treatment by CFU enumera-
tion.  S. aureus was chosen as the proxy biofilm producing 
bacterium for these experiments.  S. aureus is considered 
one of the most prevalent pathogens in wound infection,70 
and has been widely studied making it a good choice for fur-
ther investigation. Biofilms were growth on filter mem-
brane atop MHA and treated with 0.6 wt% bare Carbopol, 
0.6 wt% free Alcalase, and 0.6 wt% Alcalase coated 0.6 wt% 
Carbopol in the same fashion as above. Additionally, we in-
vestigated the effect of co-treatment with the antibiotic 
ciprofloxacin as a free agent and equivalent concentrations 





Figure 7.  (A) S. aureus biofilm cellular viability after anti-biofilm treatments.  CFU/mL of colony biofilms after timed exposure (1, 
6, 24 hr) with a variety of Carbopol Aqua SF1, Alcalase 2.4 L FG, and ciprofloxacin formulations (co-treatment and encapsulated 
in Carbopol nanogel particles).  The cell viability of S. aureus from the biofilm culture with (B) co treatments of ciprofloxacin and 
(C) treatments with encapsulated ciprofloxacin within Alcalase-coated Carbopol formulations at different dilutions at 1, 6 and 24 hr 
time-points. The treatment solutions were diluted 2-fold from a starting concentration of 0.6 wt% Carbopol-0.6 wt% Alcalase-0.0032 
wt% ciprofloxacin (co-treatment or nanogel-encapsulated).  Post-treatment, the colony biofilms were glass bead beaten in 1 mL of 
MHB with serial dilutions.  The agar drop plate method was used to elucidate the CFU/mL. Statistical analysis shown in Table S8 
(ESI).  P<0.05 is considered significant. *P < 0.05, **P < 0.01, ***P < 0.001. 
 
We have previously demonstrated that antibiotics can be 
encapsulated into Carbopol and this confers an increased 
efficacy of the antimicrobials against target cells.55  Table S5 
(ESI) shows that 75% of the ciprofloxacin encapsulated 
with the Carbopol was retained. The encapsulation effi-
ciency was measured by analyzing the supernatant of the 
formulation immediately after centrifugation, the encapsu-
lation efficiency was calculated using a standard calibration 
curve of absorption vs. known concentrations of ciprofloxa-
cin (Figure S14, ESI). Post-encapsulation, the mean particle 
diameter was marginally increased by approximately 1 nm 
post encapsulation and there was no detectable change in 
zeta potential of the nanogel particles (Figure S15, ESI).  
Previously, polyelectrolytes have been used to reverse the 
charge of nanogel and allowed an electrostatic adhesion to 
anionic surface of the bacteria.14,15,20 In this study, we used 
Alcalase to accomplish this goal to create a dual purpose 
nanocarrier able to effectively degrade the biofilm and sim-
ultaneously deliver concentrated doses of antibiotic local-
ized directly on the cell wall. This strategy is known to work 
extremely well for planktonic bacteria, but so far this has 
never been tried for bacteria in a biofilm. The release kinet-
ics of the nanogel-loaded ciprofloxacin hydrochloride was 
measured over 24 hr (Figure S16, ESI) and as in previous 
studies the antibiotic was released slowly over a period of 




Figure 8.  Fluorescent images of S. aureus biofilm formation, (A) represents an untreated control sample, (B) treat-
ment with 0.6 wt% Carbopol, (C) 0.6 wt% Alcalase 2.4 L FG , and (D) 0.6wt% Carbopol-0.6 wt% Alcalase 2.4 L FG 
nanogel particles. Samples were stained with AO.  White insert bar represents 5 μm. Tapping Mode Atomic force 
microscopy of 24-hr growth S. aureus biofilms cultured on glass slides. (E) shows biofilm growth control, (F) treat-
ment with 0.6 wt% Carbopol, (G) 0.6 wt% Alcalase 2.4 L FG and (H) 0.6 wt% Carbopol-0.6 wt% Alcalase 2.4 L FG 
nanogel particles. Images were acquired in height (topography) and then analyzed using Nanoscope Analysis v.1.7. 
(Bruker). The area scanned is 5 μm2 per image. 
 
This facilitated the release of ciprofloxacin in close proxim-
ity to the S. aureus. Cell enumeration was performed after 1, 
6, and 24 hr of treatment. The treated biofilms were glass 
bead beaten and enumerated using the drop plate method.  
Ciprofloxacin was chosen as an appropriate co-treatment as 
it can be administered topically, orally, and intravenously. 
Figure S17 (ESI) shows that the S. aureus strain used in this 
study was susceptible to ciprofloxacin and had a MIC of 0.08 
g/mL (0.000008 wt%). We chose 0.0032 wt% as this is the 
maximum concentration measured to be effective against S. 
aureus using the ETEST® strips. This allowed a fair compar-
ison of formulated vs. free ciprofloxacin at concentrations 
shown to be effective against S. aureus. Additionally, this 
concentration allows the nanocarrier colloidal stability to 
be maintained due to ciprofloxacin’s low water solubility.  
Figure 7A shows that after seeding a membrane with 1×105 
CFU/mL for 24 hr at 37 oC, the growth control continued to 
increase in cell density after a further 1, 6, and 24 hr of 
growth. Treatment with 0.6 wt% bare Carbopol showed lit-
tle change in the CFU/mL of biofilm. After treatment with 
0.6 wt% free Alcalase, there was a reduction in viable cells 
within the S. aureus biofilm. There was little difference after 
1 hr, but after 24 hr the viable cell count was reduced to just 
under 1×105 CFU/mL, very close to the concentration of 
cells the original membrane was seeded with.Surprisingly, 
after treatment with 0.6 wt% Alcalase – 0.6 wt% Carbopol 
NPs there was very little difference in the number of viable 
cells after each treatment time point. This is likely due to the 
Alcalase-Carbopol nanogel degrading the biofilm, but hav-
ing very little effect on the bacterial cell viability, as there is 
no antibiotic in this treatment to act on the released bacte-
ria. Treatment with 0.0032 wt% ciprofloxacin (higher than 
the MIC of 0.00008 wt%) was used to measure the number 
of viable cells, after 24 hrs of treatment the viable cells in 
the S. aureus biofilm had reduced from approximately 1×106 
to 1×103. The cells within the biofilm are much less suscep-
tible to antibiotics due to their poor penetration through the 
biofilm matrix. There was no real improvement when 
0.0032 wt% ciprofloxacin is treated with 0.6 wt% Carbopol. 
This result is unsurprising due to the Carbopol nanogel 
alone demonstrating no ability to degrade the biofilm ma-
trix. Again with 0.00032 wt% ciprofloxacin and 0.6 wt% 
free Alcalase there was no difference between the CFU/mL 
compared to the antibiotic alone. However, when the anti-
biotic is administered as a co-treatment with 0.6 wt% Al-
calase coated 0.6 wt% Carbopol NPs there was a reduction 
to 1×101. This indicates the cells in the biofilm have been 
destroyed due to the degradation of the biofilm matrix by 
the Alcalase-Carbopol nanogel allowing the ciprofloxacin to 
reach and penetrate the bacterial cells. This synergistic ef-
fect was enhanced further when the ciprofloxacin was de-
livered to the S. aureus in an encapsulated method, rather 
than as a separate co-treatment. After 6 hr and 24 hr of 
treatment with 0.0032 wt% ciprofloxacin encapsulated in 
0.6 wt% Carbopol with 0.6 wt% Alcalase coating there were 
no viable bacteria found in the samples. This provides evi-
dence that the dual functionality of the Alcalase-nanogel 
mediate biofilm degradation and the localized delivery of 
ciprofloxacin of this formulation is able to effectively clear 




Figure 9.  SEM images of S. aureus before (A) and after treatment with (B) 0.6 wt% bare Carbopol nanogel, (C) 0.6 
wt% free Alcalase 2.4 FG and (D) 0.6 wt% Alcalase 2.4G coated 0.6 wt% Carbopol nanogel. All samples were prepared 
for SEM imaging by drying and coated with ∼10 nm carbon layer. Samples were imaged using a Carl Zeiss Evo-60 
(Germany) with a variable pressure 100 m aperture at 40 Pa. EHT was 20 kV with probe current of 100 pA. Images 
were captured with Zeiss smartSEM software. 
 
Figure 7B shows that there is a correlation between the in-
creasing of the concentration of free ciprofloxacin in the 
presence of equivalent amount of Alcalase-Carbopol NPs 
and the residual bacterial cell viability after treatment. Dif-
ferent dilutions of the treatments were prepared to meas-
ure this effect. A very low treatment concentration, 0.075 
wt% Alcalase – 0.075 wt% Carbopol + 0.0004 wt% ciprof-
loxacin, showed very little effect after 1, 6, or 24 hrs. This is 
due to the likely ineffective degradation of the biofilm. How-
ever, as the concentration of the Alcalase-Carbopol NPs in-
creased alongside the increased concentration of ciproflox-
acin, CFU/mL was reduced to almost no viable cells. After 
24 hrs at the higher concentration of the formulation, there 
was very little difference in the CFU at the 1, 6, and 24 hr 
time points, this indicates the Alcalase-coated nanogel par-
ticles are very fast acting, enabling the ciprofloxacin access 
to the cells quickly. Interestingly, at the mid-treatment con-
centrations CFU/mL increased between 1 hr and 6 hr, how-
ever a 24 hr it had fallen below the first time point. This in-
dicates the lower concentrations of Alcalase-Carbopol NPs 
are slower to effect the biofilms. 0.6 wt% Alcalase – 0.6 wt% 
Carbopol nanogel was found to be the most effective con-
centration to kill cells with in a biofilm when combined with 
the synergistic effect of ciprofloxacin. Figure 7C shows the 
results on the concentration dependence of the cell viability 
on the antibiotic treatment in experiments where the 
ciprofloxacin was encapsulated within the Carbopol nano-
gel, rather than being delivered separately as a co-treat-
ment. We were able to show that there was a significant de-
crease in cell viability after 1, 6 and 24 hr compared to when 
ciprofloxacin was administered separately at the same con-
centration. We attribute this to the highly localized release 
of ciprofloxacin from the adhered nanogel enhancing the ef-
fect of the antibiotic. Alcalase-functionalized Carbopol 
nanogel particles can be seen attached to the bacterial cell 
after the biofilm has been cleared away (Figure 9D) provid-
ing evidence of their ability of local delivery antibiotic di-
rectly to the bacterial cell wall.  
Anti-biofilm efficacy of Alcalase-nanogel particles on S. 
aureus biofilm structure.  We also investigated how 0.6 
wt% Alcalase –coated 0.6 wt% Carbopol nanogel affects the 
biofilm structure of S. aureus using fluorescence micros-
copy.  S. aureus was allowed to adhere to a glass slide which 
has been submerged in this culture for 24 hr at 37 oC. After 
24 hr the media was removed and the glass slides washed 
to remove non-sessile cells. Supplemented fresh media con-
taining 0.6 wt% Carbopol, 0.6 wt% free Alcalase, and 0.6 
wt% Alcalase – 0.6 wt% Carbopol NPs was incubated for a 
further 24 hrs covering the slides. Acridine Orange (AO) 
was used to visualize the remaining cells after treatment. 
AO is a cell-permeable nucleic acid selective fluorochrome 
dye. It can emit green light at 520 nm when intercalated 
with dsDNA. Figure 8A shows the growth control has a 
highly congested biofilm structure, the cells are highly 
packed which is consistent with biofilm formation. There is 
very little difference to the biofilm structure after treatment 
with 0.6 wt% bare Carbopol and 0.6 wt% free Alcalase (Fig-
ure 8B, 8C). The cells remain packed densely together, alt-
hough there is a moderate reduction in the cell density 
16 
 
when treated with free Alcalase. However, in Figure 8D, 
there is a marked reduction in the intensity of the AO fluo-
rescence and a reduction in the cell density. The cells have 
much lower surface density. This suggests the disruption of 
the biofilm matrix by the Alcalase-Carbopol nanogel parti-
cles has allowed many of the cells to detach from the biofilm 
during treatment, or during the followed washing.  For bet-
ter understanding of the S. aureus biofilm structure, the 
same samples used for fluorescent analysis were imaged us-
ing AFM (Figure 8E-H). The AFM images again show how 
the 0.6 wt% Alcalase – 0.6 wt% Carbopol NPs effectively re-
move the biofilm from the glass slide.  
Figure 8E shows the tightly packed biofilm with staphylo-
coccal cells of thickness approximately 1 μm; the cells ap-
pear to be in a multilayer due to the height sensor recording 
a maximum height of 2.2 μm. There was no clear differences 
in structure between the treatments of 0.6 wt% bare Carbo-
pol nanogel and 0.6 wt% free Alcalase treatments (Figures 
8F and 8G, respectively). There is only a very small reduc-
tion in the average thickness of the biofilm of 0.1 μm which 
is insignificant. The AFM scans again show staphylococcal 
layer of approximately 1 μm in a tightly packed fashion. In 
the control, 0.6 wt% bare Carbopol nanogel and 0.6 wt% 
free Alcalase there was no discernible difference in cellular 
morphology. The image in Figure 8H, however, shows the 
biofilm structure has largely been removed, in the scanned 
region there were no obvious signs of cell adherence and 
the peak height was 0.5 μm which is half the average diam-
eter of an S. aureus cell. This results indicates that the cells 
have been removed during the Alcalase-Carbopol nanogel 
treatment, and washed away after treatment during the 
preparation of the glass slides for AFM microscopy. This 
correlates with the data obtained in the AO fluorescence mi-
croscopy images. Finally, we investigated the structure of 
the S. aureus biofilm using scanning electron microscopy 
(SEM). In this case, we used biofilms grown of filter mem-
branes as this allowed feasible samples to be obtained for 
SEM analysis. The samples were prepared in the same man-
ner as described in the cellular viability assays of biofilm 
grown S. aureus reported above. The biofilms were treated 
with 0.6 wt% bare Carbopol nanogel, 0.6 wt% free Alcalase, 
and 0.6 wt% Alcalase–coated 0.6 wt% Carbopol nanogel 
particles. Un-supplemented media was considered the 
growth control. After the treatment, the biofilm membranes 
were gently removed from the agar using serial tweezers, 
however, instead of enumeration the membrane was 
washed in deionized water, fixed for 1 hr in 1 wt% glutaral-
dehyde, dehydrated in ethanol and dried in liquid CO2 at 
critical point as described in the methods section. 10 nm of 
carbon coating was used to create a conductive layer over 
the biofilm, and reduce thermal damage during SEM imag-
ing.   
Figure 9 shows the SEM images after the treatments. The 
control sample shows the highly congested S. aureus bio-
film. At higher magnification, the EPS within the matrix can 
also be seen adhered to the surface of the coccus cells and 
linked to other cells around, consistent with biofilm for-
mation. This morphology is similar in the samples with 0.6 
wt% free Carbopol nanogel treatments. The cell density re-
mains highly analogous to the control sample and EPS ma-
trix can be observed around the cells. The cells appear to 
also be in multilayer with cells atop one and other.  Interest-
ingly, in the sample treated with free 0.6 wt% Alcalase, the 
cellular morphology and density remain largely unchanged, 
however, there appears to be a distinct lack of EPS matrix 
coating and surrounding the cells. This indicates the Al-
calase may have digested the biofilm matrix but left the cells 
largely untouched. Finally, the sample treated with the Al-
calase-Carbopol NPs there is a clear reduction the cell den-
sity and additionally the biofilm EPS matrix has been de-
graded. The Alcalase-Carbopol nanogel particles can also be 
seen adhered to the surface of the S. aureus cells, due to the 
cationic protease molecules on the nanogel surface having 
an electrostatic attraction to the anionic surface of the bac-
terial cell wall. This data correlates to the images seen using 
fluorescence and atomic force microscopy, and confirms 
that the Alcalase-Carbopol nanogel particles are degrading 
the biofilm glycoprotein network.   
Zeta potential of bacteria treated with free Alcalase and 
Alcalase-nanogel. We also investigated the effect the free 
Alcalase and the immobilized Alcalase on-Carbopol nanogel 
on the zeta potential of the bacterial species.  The experi-
ments on the cells were performed in suspension in allow 
zeta potential measurements by DLS. Figure S12 (ESI) indi-
cates that all six species conferred a negative charge on their 
cells walls, with the Gram-negative generally having a 
stronger charge than the Gram-positive.  
Across all six species, the free Alcalase showed a marginal 
reduction in the negative charge after 10 mins and 1 hr. This 
was likely due to the accumulation of protease on the cell 
wall. The charge difference was only slight between 10 mins 
and 1 hr, indicating the Alcalase protease had not built up 
and saturated the surface of the cells.  In contrast, the Al-
calase-Carbopol nanogel particles showed an increased re-
duction of the negative charge of the bacterial cells. On av-
erage, this was reduced by approximately 7-10 mV across 
the six species. This indicated a buildup of the cationic pro-
tease-coated nanogel carriers on the surface on the bacte-
rial cells. The SEM images of S. aureus in Figure 9D also sup-
port this data, showing the Alcalase-Carbopol particles ad-
hered to the bacterial cell wall.  The experiments where 
stopped after 1 hr due to the aggregation of the cells causing 
unreliable zeta potential measurements. Whilst these ex-
periments are not indicative of the behavior of the cells in a 
biofilm, which will have a much more complex EPS matrix 
surrounding them, it does provide a valuable insight into 
the increased attraction of the Alcalase-Carbopol nanogel to 
the exposed bacterial cells, and therefore the likely in-
creased affinity of these particles to protein structures 
within the biofilm matrix.  
Comparison with standard treatments for biofilm form-
ing bacteria. Currently, there is no Gold Standard when it 
comes to topically treating wound biofilms. There is univer-
sal agreement that mechanical debridement is the most ef-
fective way of remove biofilm infection, but this is not al-
ways possible and often results in regrowth of the biofilm 





Figure 10.  S. aureus biofilm cellular viability after 24 hours at different concentrations of alternative treatments.  (A) Shows 
alternative biofilm treatments at 0 to 0.0062 wt% to compare to the active concentration of ciprofloxacin in the Carbopol-
Alcalase formulation.  (B) Shows a comparison a comparison of the alternative biofilm treatments at concentrations used 
clinically. Biofilm treatments were 0.6 wt% Carbopol-0.0032 wt% Ciprofloxacin-0.6 Alcalase, Chlorhexidine digluconsate, 
Iodine and Poly(vinylpyrrolidone)-Iodine (PVP-I).  Post-treatment, the membrane biofilms were washed thrice and then 
glass bead beaten in 1 mL of MHB with serial dilutions. The agar drop plate method was used to elucidate the CFU/mL.  
Black scale bar in the biofilm pictures is 0.5 cm.    
Long term antibiotic treatment and topical antimicrobial 
treatments are other common options in treating biofilms.  
After decades of use, iodophore-based formulations such as 
Poly(vinylpyrrolidone)-Iodine (PVP-I) remain prevalent in 
wound biofilm treatments.71 Iodine based agents are effec-
tive antimicrobial agents, which are tolerated well by the 
body and offer a broad spectrum of activity.72 Additionally, 
they are able to penetrate biofilms, and no clinical evidence 
presently shows they have a negative effect on wound heal-
ing.73 Chlorohexidine is also often used to as a disinfectant 
on patients and is commonly found in formulations de-
signed to reduce infection. However, it is not known to be 
effective against cells within biofilms.74 Figure 10 shows a 
comparison between 0.6 wt% Carbopol-0.0032 wt% Ciprof-
loxacin-0.6 wt% Alcalase nanogels against Iodine, PVP-I and 
chlorhexidine using the membrane biofilm model. The re-
sults show that at the concentrations similar to active agent 
in our formulation, ciprofloxacin, the alternative treatments 
are ineffective. This is likely due requirement of higher con-
centrations needed to be effective and the lack of penetra-




Figure 11.  (A) HaCaT cell viability after comparative treatment with 0.6 wt% Carbopol Aqua SF1 nanogel, 0.6 wt% Alcalase 
2.4 L FG, and -0.6 wt% Alcalase–coated 0.6 wt% Carbopol nanogel particles.  Viability counts were performed at 1, 6, and 24 
hr.  (B) HaCaT cell status after 24 hr untreated or 24 hr of 0.6 wt% Alcalase-0.6 wt% Carbopol treatment.  (C) shows the dot 
plot distribution for untreated cells after 24 hr and (D) shows the dot-plot distribution for 0.6 wt% Alcalase-0.6 wt% Car-
bopol treatment after 24 hr.  The experimental was ended after 104 cells were counted after staining using a FITC Annexin 
staining kit.  Figure S19 (ESI) shows the results for the 0.6 wt% Carbopol and 0.6 wt% Alcalase which were considered con-
trols.  Figure S20 (ESI) shows photographs of the HaCaT cells after 24 hr treatment and Table S7 (ESI) shows the cell status 
after 24 hrs of treatment.   
 
The quenching effective of the EPS is paramount in preserv-
ing cell viability within a biofilm. Additionally, we tested the 
effect of 0.2 wt% chlorhexidine, and 10 wt% PVP-I, concen-
trations which are commonly used clinically in wound 
cleaning and sterilization. 73,75 Again, the results follow the 
same trend as the low concentrations, with neither agent 
able to fully eliminate the biofilm bacteria viability.  
Cytotoxicity and apoptosis inducing ability of bare 
nanogel, free Alcalase, and Alcalase-nanogel on human 
cells. A preliminary human cell cytotoxicity experiment 
was performed on HaCaT cells to investigate if the bare Car-
bopol Aqua SF1, the free Alcalase 2.4 L FG, and the Alcalase 
2.4 L FG-coated Carbopol Aqua SF1 nanogel particles were 
toxic to human cells. HaCaT cells are very good proxy for 
studying cytotoxicity of the treatment as they are human 
keratinocytes which are the same type of cells likely to be 
exposed to the formulation in chronic wound cells. Figure 
11A shows that 0.6 wt% Carbopol showed only a marginal 
reduction in viable cells over 1, 6, and 24 hrs. This was also 
the case with 0.6 wt% free Alcalase 2.4 L FG, and Alcalase 
2.4 L FG-coated 0.6 wt% Carbopol Aqua SF1 nanogels, the 
same formulations used in the anti-biofilm experiments. 
This indicates that the Alcalase-coated Carbopol nanogels 
confer only a slight increase in cytotoxicity towards the Ha-
CaT cells, compared with the free enzyme and the bare 
nanogel. The data indicates that the enzyme concentration 
which provided effect anti-biofilm effect had very little im-
pact on cell viability, providing evidence they may be appro-
priate for in vivo use in surface chronic wounds. Addition-
ally, we investigated the effect the 0.6 wt% Alcalase-0.6 
wt% Carbopol nanogel particles on inducing apoptosis after 
24 hrs treatment. An Annexin V-FITC staining kit was used 
to measure the induction of apoptosis using FACS (Fluores-
cence-activated cell sorting). Figure 11B shows that after 24 
hrs exposure to the Alcalase-coated Carbopol nanogel there 
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was approximately a 10% residual viable cells compared to 
untreated cells, which correlates well with the MTT viability 
data shown in Figure 11A. There is only a marginal differ-
ence in induced apoptosis (cells staining positive for An-
nexin and negative for PI).  This indicates that the Alcalase 
2.4 FG protease is not triggering apoptosis by way of the 
caspases cascade apoptosis pathway. 
CONCLUSIONS 
Our results confirm that protease Alcalase 2.4 L FG can dis-
rupt the bacterial biofilm EPS matrix and reduce its bio-
mass. The surface functionalization of Carbopol Aqua SF1 
nanogels with this enzyme further boosts this effect on six 
wound biofilm associated pathogens reducing the biomass 
6-fold compared to untreated biofilms. The efficacy of the 
Alcalase-coated Carbopol nanogel particles was confirmed 
using fluorescence, atomic force and scanning electron mi-
croscopy. Additionally, the application of Alcalase-Carbopol 
nanogels in a co-treatment with ciprofloxacin resulted in a 
3-log reduction in viable cells counts compared to using of 
equivalent concentration of ciprofloxacin alone. When 
ciprofloxacin was encapsulated within Carbopol at equiva-
lent concentrations to the free ciprofloxacin, there was a 
very significant further boost to the effectiveness of the an-
tibiotic in this dual functionalized nanocarrier. These dual 
purpose Alcalase-coated antibiotic loaded nanogel particles 
provided effective treatment against S. aureus biofilms, with 
no detectable CFU after 6 hr and 24 hr treatment times. The 
Alcalase-Carbopol nanogels also showed negligible cytotox-
icity and apoptosis inducing influence towards adult human 
keratinocytes. We conclude that the Alcalase-coated and 
ciprofloxacin loaded Carbopol nanogel carrier are an effec-
tive and apparently safe anti-biofilm formulation which 
could provide an alternative approach to treatment of ex-
ternal wound biofilms. We believe further investigation of 
the practical administration of Acalase-coated Carbopol 
nanogels loaded with antibiotics on biofilm infected 
wounds is required, where these nanogels could provide an 
advantageous tool for therapeutic anti-biofilm treatments 
and fight against antimicrobial resistance. 
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Figure S1.  Schematic of the enzymatic degradation of peptide bonds in proteins by Alcalase 2.4 L FG.  
Alcalase 2.4 L FG acts as a hydrolases cleaving peptide chains.  It also acts as esterase, enabling it to 
catalyse stereo-selective hydrolysis of some esters including carboxylic esters and amino esters. 
 
 
Figure S2.  TEM images showing the comparison between (A) bare Carbopol Aqua SF1 nanogel 
particles and (B) Alcalase 2.4 L FG-coated Carbopol Aqua SF1 nanogel particles.  As shown in the 
images, the coated NPs have a slight grainy and irregular surface texture caused by the coating with 
the protease.  The coated NPs are also slight larger which is consistence with measurement taken by 







Figure S3.  Photographs of (A) 0.6 wt Carbopol Aqua SF1, (B) 0.6 wt% Alcalase 2.4 L FG, and (C) 0.6 wt% 











Figure S4.  Fourier transform infra-red (FTIR) spectra of Carbopol Aqua SF1, Alcalase 2.4 L FG, Ciprofloxacin 
and Carbopol encapsulated Ciprofloxacin coated with Alcalase NPs.  Samples were prepared by removing 
water using a Silica gel desiccant by in vacuum chamber for 1 day, then dried at 60 oC for 2 days.  The spectra 
was measured between 4000-600 cm-1 using PIKE ATR diamond settings.  A spectrum was obtained with a 










Figure S5.  EDX spectra of (A) Carbopol Aqua SF1, (B) Alcalase 2.4 L FG, (C) Ciprofloxacin and (D) 0.6 
wt% Carbopol-0.0032 wt% Ciprofloxacin-0.6 wt% Alcalase NPs.  The measurement for Carbopol, 
Alcalase and Ciprofloxacin was taken three separate locations and the data averaged.  The 
measurement for the NP was taken in the centres of three separate NPs and averaged.  A Hitachi 
TM3030Plus and Oxford Laboratories micF+ X-stream-2 EHX was used, and the data analysed using 
Aztec One v.3.3. 
 
 
Figure S6.  Alcalase 2.4 L FG enzymatic characteristics.  (A) Effect of pH on Alcalase activity, (B) effect 













Type Form Optimal Usage 
Conditions 
Activity Applications 






Liquid 30–65°C pH 7–9 2.4 AU-A/g 
  
Table S2.  Biofilm formation visual score 
Bacteria Species Biofilm score 
S. aureus 3-strong 
P. aeruginosa 3-strong 
S. epidermidis 3-strong 
K. pneumoniae 2-moderate 
E. coli 2-moderate 
E. faecalis 1-weak 
The formation of biofilm by staining of adhered cells was scored as either 0-absent, 1-weak, 2-




Figure S7.  Relative activity of 0.2 wt% free Alcalase 2.4 L FG vs 0.2 wt% Alcalase 2.4 L FG- 0.2 wt% 
Carbopol Aqua SF1 NPs.  (A) shows the effect of pH, (B) temperature, and (C) time.  Each value 










Figure S8.  Qualitative tube method of biofilm formation detection photographs. Cells and biofilm 
mass are stained blue/purple by the Crystal Violet dye. 
 
Figure S9.  Congo Red Agar (CRA) biofilm detection method photographs.  Black colonies indicated the 
species is a biofilm producer.  Agar formulated using 37 g/L Brain Heart Infusion agar, 0.8 g/L Congo 
Red, and 6 g/L sucrose. CRA has a very low sensitivity compared to other biofilm detection methods 



































Table S3.  Crystal Violet staining statistical analysis between 0.2 wt% Alcalase 2.4 L FG and 0.2 wt% 
Alcalase 2.4. L FG-0.2 wt% Carbopol Aqua SF1.  Data were expressed as average values ± standard 
deviations of the mean. P-values of less than 0.05 were considered significant.  All Student’s T-tests 
were performed in GraphPad v7.0.4. 
Species Multiple Comparison P-value Significance 
S. aureus 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.015841 * 
P. aeruginosa 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.000579 *** 
S. epidermidis 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.000387 *** 
K. pneumoniae 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.014732 * 
E. coli 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.000264 *** 
E. faecalis 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.001023 ** 
< 0.05 is considered significant. *P <0.05, **P <0.01, ***P <0.001 
 
 
Table S4.  Congo Red staining statistical analysis between 0.2 wt% Alcalase 2.4 L FG and 0.2 wt% 
Alcalase 2.4. L FG-0.2 wt% Carbopol Aqua SF1.  Data were expressed as average values ± standard 
deviations of the mean. P-values of less than 0.05 were considered significant.  All Student’s T-tests 
were performed in GraphPad v7.0.4. 
Species Multiple Comparison P-value Significance 
S. aureus 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.00526 ** 
P. aeruginosa 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.001446 ** 
S. epidermidis 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.000657 *** 
K. pneumoniae 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.007448 ** 
E. coli 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.004157 ** 
E. faecalis 0.2 wt% Alcalase vs 0.2 wt% Alcalase-0.2 wt% Carbopol 0.000636 *** 








Figure S12.  The zeta potential of bacterial cells treated with either 0.2 wt% free Alcalase or 0.2 wt% 
Alcalase-0.2 wt% Carbopol NPs.  The bacteria / treatment suspension was placed in a quartz cuvette 
and zeta potential was measured using the Dipstick probe and Malvern Zetasizer nano ZS. The 


















Figure S13.  Photographs of S. aureus biofilms surface after treated with Resazurin Sodium Salt reagent.  
Pink indicates metabolising cells, purple non-metabolising cells.  Black scale bar represents 1 cm. 
 
 




































Figure S14.  Standard calibration graphs of the absorption vs concentrations of ciprofloxacin 
hydrochloride. Absorbance was measured at 280 nm. Aliquots were prepared by adding ciprofloxacin 






Figure S15.  The (A) size and (B) zeta potential of 0.6 wt% Carbopol, 0.6 wt% Carbopol encapsulating 
0.0032 wt% ciprofloxacin and 0.6 wt% Carbopol encapsulating 0.0032 wt% ciprofloxacin with 0.6 wt% 
Alcalase coating.  All measurements were taken at pH 5.5 (acetate buffer solution) with a RI of 1.450 






Figure S16.  Ciprofloxacin release kinetics at pH 5.5.  10 mL of 0.0032 wt% ciprofloxacin-0.6 wt% 
Carbopol suspension was placed into a 10-12 kDa MWKO dialysis bag.  The dialysis bag was submerged 
into 250 mL of pH 5.5 acetate buffer at 37 oC whilst shaken at 100 rpm shaking. 1 mL aliquots were taken at 
specific time points on the absorbance of the aliquot equated into the concentration of ciprofloxacin in the 
acetate buffer using a standard calibration curve. Absorption was measured at 280 nm. Each value 





Figure S17.  Ciprofloxacin MIC ETEST® Evaluator strips 32-0.002 μg/mL tested against S. aureus.  






























Figure S18.  Calibration curve of HaCaT cells.  Various cell concentrations were seeded in DMEM 
medium and absorption values obtained at 570 nm.  These data were used to calculate the number 




Figure S19.  HaCaT cell status after 24 hrs of treatment with (A) 0.6 wt% Carbopol and (B) 0.6 wt% 








Figure S20.  Photographs of HaCaT cells in 96-well plates after 24 hour treatment of (A) untreated 
control, (B) 0.6 wt% Alcalase-0.6 wt% Carbopol NPs, (C) 0.6 wt% bare Carbopol and (D) 0.6 wt% free 
Alacalase.  Photographs were taken immediately after treatment and before treatment infused DPBS 






Table S6.  The elemental analysis of Carbopol Aqua SF1, Alcalase 2.4 L FG, Ciprofloxacin, and 
Ciprofloxacin-loaded Carbopol nanogel coated with Alcalase 2.4 L FG. 
 
Element 0.6 wt% Carbopol 
Aqua SF1 / % 
0.6 wt% Alcalase 
2.4 L FG / % 
0.0032 wt% 
Ciprofloxacin / % 
0.6 wt% Carbopol Aqua SF-
1-0.0032 wt% 
Ciprofloxacin-0.6 wt% 
Alcalase 2.4 L FG / % 
C 35.93 47.60 51.08 41.19 
H 5.83 6.59 6.00 5.71 
N 0.0 16.58 10.60 7.57 
S 0.0 0.48 0.0 0.26 
 
 
Table S7.  Cell status of HaCaT cells measured using FITC Annexin V staining kit and FACS. 
Treatment Cell status 
Viable cells Dead cells Apoptotic cells 
Untreated cells 87.4 % 7.2 % 5.4 % 
0.6 wt% Carbopol-0.6 wt% Alcalase NPs 73.6 % 22.3 % 4.1 % 
0.6 wt% Carbopol 86.2 % 7.6 % 6.2 % 
0.6 wt% Alcalase 75.1 % 20.4 % 4.5 % 
 
 
Table S8.  Statistical analysis of free ciprofloxacin vs encapsulated ciprofloxacin (0.6 wt% Alcalase-0.6 
wt% Carbopol formulation) at 1, 6 and 24-hour time points.  Data were expressed as average values ± 
standard deviations of the mean. P-values of less than 0.05 were considered significant.  All Student’s 
T-tests were performed in GraphPad v7.0.4. 
Multiple comparison P-value Significance 
1 hour free ciprofloxacin VS 1 hour encapsulated ciprofloxacin (0.6 
wt% Carbopol-0.6 wt% Alcalase NP) 
0.001952 ** 
6 hour free ciprofloxacin VS 1 hour encapsulated ciprofloxacin (0.6 
wt% Carbopol-0.6 wt% Alcalase NP) 
0.000314 *** 
24 hour free ciprofloxacin VS 1 hour encapsulated ciprofloxacin (0.6 
wt% Carbopol-0.6 wt% Alcalase NP) 
0.000499 *** 
< 0.05 is considered significant. *P <0.05, **P <0.01, ***P <0.001 
 
 
